Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: A feasibility study

British Journal of Cancer

Volumn 111, Issue 4, 2014, Pages 790-798

  Gruber, M ^a   Tisch, U ^b   Jeries, R ^b   Amal, H ^b   Hakim, M ^b   Ronen, O ^a   Marshak, T ^a   Zimmerman, D ^b   Israel, O ^b   Amiga, E ^b   Doweck, I ^a   Haick, H ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

breath; diagnosis; GCMS; head and neck cancer; nanotechnology; sensor; staging; volatile organic compound

Indexed keywords

ALCOHOL; ALKANE; NANOMATERIAL; NITRILE; PROPIONITRILE; UNCLASSIFIED DRUG; UNDECANE;

ADULT; ALGORITHM; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; CANCER STAGING; CHEMICAL ANALYSIS; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; EXPIRED AIR; FEASIBILITY STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH CARE COST; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; PHARYNX CARCINOMA; PRIORITY JOURNAL; SENSOR;

AGED; BREATH TESTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; EXHALATION; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VOLATILE ORGANIC COMPOUNDS;

EID: 84906088842     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.361     Document Type: Article

References (40)

1. Amal H, Ding L, Liu BB, Tisch U, Xu ZQ, Shi DY, Zhao Y, Chen J, Sun RX, Liu H (2012) The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomedicine 7: 4135-4146.
2. Amal H, Leja M, Broza YY, Tisch U, Funka K, Liepniece-Karele I, Skapars R, Xu ZQ, Liu H, Haick H (2013) Geographical variation in the exhaled volatile organic compounds of gastric cancer. J Breath Res 7: 047102.
3. Amann A, Miekisch W, Pleil J, Risby T, Schubert J (2010) Methodological issues of sample collection and analysis of exhaled breath. European Respiratory Society Monograph 49: 96-114.
4. Amann A, Spanel P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 7(2): 115-129.
5. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371(9625): 1695-1709.
6. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 9: 348.
7. Barash O, Peled N, Hirsch FR, Haick H (2009) Sniffing the unique 'odor print' of non-small-cell lung cancer with gold nanoparticles. Small 5(22): 2618-2624.
8. Broza YY, Haick H (2013) Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine 8(5): 785-806.
9. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J (2010) TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in-vitro. Cancer Epidemiol Biomarkers Prev 19: 182-195.
10. Garćia RA, Morales V, Mart́in S, Vilches E, Toledano A (2014) Volatile organic compounds analysis in breath air in healthy volunteers and patients suffering epidermoid laryngeal carcinomas. Chromatographia 77: 501-509.
11. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, Oneill HJ (1985) Volatile organic-compounds in exhaled air from patients with lung-cancer. Clin Chem 31: 1278-1282.
12. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11): 1143-1154.
13. Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A (2014) Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev 43: 1423-1449.
14. Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, Abdah-Bortnyak R, Kuten A, Haick H (2011) Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer 104(10): 1649-1655.
15. IARC (1999) Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71, pp. 43-108. World Health Organization Distribution and Sales: Geneva.
16. Ionescu R, Broza YY, Shaltieli H, Sadeh D, Zilberman Y, Feng X, Glass-Marmor L, Lejbkowicz I, Müllen K, Miller A, Haick H (2011) Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem Neurosci 2(12): 687-693.
17. Ionescu R, Llobet E, Vilanova X, Brezmes J, Sueiras JE, Calderer J, Correig X (2002) Quantitative analysis of NO2 in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing. Analyst 127: 1237-1246.
18. Jones AW (1985) Excretion of low-molecular weight volatile substances in human breath: focus on endogenous ethanol. J Anal Toxicol 9(6): 246-250.
19. Kneepkens CM, Lepage G, Roy CC (1994) The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 17(2): 127-160.
20. Konvalina G, Haick H (2014) Sensors for breath testing: from nanomaterials to comprehensive disease detection. Acc Chem Res 47(1): 66-76.
21. Leunis N, Boumans ML, Kremer B, Din S, Stobberingh E, Kessels AG, Kross KW (2013) Application of an electronic nose in the diagnosis of head and neck cancer. Laryngoscope 124(6): 1377-1381.
22. Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Klieber M, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med 47(5): 550-560.
23. Marur S, D'Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11: 781-789.
24. Mendis S, Sobotka PA, Euler DE (1994) Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath. Clin Chem 40: 1485-1488.
25. Miekisch W, Schubert JK, Noeldge-Schomburg GFE (2004) Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 347: 25-39.
26. Neumark YD, Lopez-Quintero C, Grinshpoon A, Levinson D (2007) Alcohol drinking patterns and prevalence of alcohol-abuse and dependence in the Israel National Health Survey. Isr J Psychiatry Relat Sci 44(2): 126-135.
27. O'Neill HJ, Gordon SM, O'Neill MH, Gibbons RD, Szidon JP (1988) A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem 34: 1613-1618.
28. Pai SI, Westra WH (2009) Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4: 49-70.
29. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Haick H (2009) Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4(10): 669-673.
30. Peng S, Hakim M, Broza Y, Billan S, Abdah-Brotnyak R, Kuten A, Tisch U, Haick H (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103: 542-551.
31. Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, McVay WP (1999) Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353: 1930-1933.
32. Phillips M, Greenberg J, Awad J (1994) Metabolic and environmental origins of volatile organic compounds in breath. J Clin Pathol 47: 1052-1053.
33. Schmutzhard J, Rieder J, Deibl M, Schwentner IM, Schmid S, Lirk P, Abraham I, Gunkel AR (2008) Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors. Head Neck 30(6): 743-749.
34. Shuster G, Gallimidi Z, Heyman-Reiss A, Dovgolevsky E, Billan S, Abdah-Bortnyak R, Kuten A, Engel A, Shiban A, Tisch U, Haick H (2010) Classification of breast cancer precursors through exhaled breath. Breast Cancer Res Treat 126: 791-796.
35. Song G, Qin T, Liu H, Xu G, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD (2010) Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 67(2): 227-231.
36. Sponring A, Filipiak W, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J (2009) Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res 29: 419-426.
37. Tisch U, Aluf Y, Ionescu R, Nakhleh M, Bassal R, Axelrod N, Robertman D, Tessler Y, Finberg JPM, Haick H (2012) Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. ACS Chem Neurosci 3(3): 161-166.
38. Tisch U, Haick H (2010a) Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev Chem Eng 26: 171-179.
39. Tisch U, Haick H (2010b) Sensors based on monolayer-capped metal nanoparticles. In Chemical Sensors, Schwank J, Korotcenkov G (eds), Vol. 2: Nanostructured Materials, pp 141-202. Momentum Press: New York.
40. Wilkoxon F (1945) Individual comparisons by ranking methods. Biometrics Bull 1: 80-83.